Healthy adult
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects who fully understand significance, content and purpose of this study and who agree to participate in this study with a written informed consent. 2. Post-menopausal Japanese women.
Exclusion criteria
Exclusion criteria: 1. Subjects who are under physician's advice, treatment, and/or medication for diabetes, renal disease, galactosemia, osteoporosis, thyroid dysfunction, hypertension, dyslipidemia, gastrointestinal diseases. 2. Subjects who use pacemakers and/or defibrillators. 3. Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal, respiratory diseases, and/or affected with infectious diseases requiring reports to the authorities. 4. Subjects with major surgical history relevant to the digestive system. 5. Subjects with unusually high and/or low blood pressure, abnormal physical data and/or abnormal hematological data. 6. Subjects with severe anemia. 7. Post-menopausal women complaining of obvious physical changes. 8. Subjects who are at risk of having allergic reactions to drugs and/or foods especially based on milk, eggs, wheat, sesame, mackerel, soy beans, apples, etc. 9. Subjects with lactose intolerance, and/or who be unable to drink a cup of milk (200 ml) within 5 minutes. 10. Subjects who regularly take medicine, functional foods, and/or supplements which would affect mineral absorption. 11. Heavy smokers, alcohol addicts or subjects with disordered lifestyle. 12. Subjects who donated either 400 ml whole blood within 16 wks, 200 ml whole blood within 4 wks, or blood components within 2 wks, prior to this study. 13. Pregnant or lactating women or women who expect to be pregnant. 14. Subjects who currently participate in other clinical trials, or participated within the last 4 wks prior to this study. 15. Subjects who are ineligible due to physician's judgment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area Under the Curve of Urinary mineral (Ca, Mg, Fe, Zn) /creatinine ratio | — |
Secondary
| Measure | Time frame |
|---|---|
| Urinary mineral (Ca, Mg, Fe, Zn) /creatinine ratio Calcitonine in blood Urinary NTx/creatinine ratio Urinary DPD/creatinine ratio | — |
Countries
Japan
Contacts
Hokkaido Information University Health Information Science Center